Overview

概述
  • 文章类型: Journal Article
    我们进行了一项概述,以评估与COVID-19疫苗相关的免疫不良反应,指导更安全的选择,并为临床医生提供循证信息。
    回顾了PubMed关于疫苗不良反应的43项研究,Embase,和WebofScience。单臂荟萃分析估计的汇总效果,发病率,介绍,等。使用单臂荟萃分析进行概述,并根据“系统评价和荟萃分析(PRISMA)的首选报告项目”中概述的指南报告了发现,该报告专门针对心肌炎和血栓形成。在筛选了2591篇文章后,42项研究符合纳入标准。使用AMSTAR2评估方法学质量。分歧通过协商一致解决。数据分析利用R软件中的随机效应模型来估计所选不良事件的发生率。
    在删除1,198个重复项并从总共2,591个中筛选出无关文章后,我们纳入了42个研究。接种疫苗的不良反应包括心肌炎,血栓形成,皮肤反应,GBS,等。血栓形成和心肌炎是与疫苗接种相关的最危险的疾病。6%的Vector疫苗接种者发生心肌炎,与61%的mRNA疫苗接种者相比。Vector疫苗接种后(91%)血栓形成比mRNA疫苗接种后(9%)更常见。此外,8项研究进行了抗PF4抗体检测,阳性率为67%.Meta分析显示,在所有疫苗诱导的血栓性血小板减少症患者中,66%的患者发生脑静脉窦血栓,43%发生颅内出血。接种疫苗的患者深静脉血栓形成和肺血栓栓塞的发生率分别为13%和23%,分别,合并病例死亡率为30%。
    本概述的结果表明,大多数不良反应是自限性的,需要最少的干预,而心肌炎和血栓形成等罕见事件构成潜在的致命威胁。
    UNASSIGNED: We conducted an overview to assess immune adverse effects associated with the COVID-19 vaccine, guiding safer choices and providing evidence-based information to clinicians.
    UNASSIGNED: Forty-three studies on adverse effects of vaccines were reviewed from PubMed, Embase, and Web of Science. Single-arm meta-analyses estimated summary effects, incidence, presentation, etc. An overview using single-arm meta-analysis and reported the findings following the guidelines outlined in the \'Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) specifically focusing on myocarditis and thrombosis. After screening 2,591 articles, 42 studies met the inclusion criteria. Methodological quality was evaluated using AMSTAR 2. Disagreements were resolved via consensus. Data analysis utilized a random-effects model in R software to estimate incidence rates of selected adverse events.
    UNASSIGNED: After removing 1,198 duplicates and screening out irrelevant articles from a total of 2,591, we included 42 studies. Adverse reactions to vaccinations include myocarditis, thrombosis, skin reactions, GBS, etc. thrombosis and myocarditis are the most dangerous diseases associated with vaccination. Myocarditis occurred in 6% of Vector vaccine recipients, compared to 61% of mRNA vaccine recipients. Thrombosis was more common after Vector vaccination (91%) than after mRNA vaccination (9%). Furthermore, eight studies conducted anti-PF4 antibody tests and yielded a positivity rate of 67%. Meta-analysis showed that among all patients with Vaccine-induced Thrombotic Thrombocytopenia, cerebral venous sinus thrombosis occurred in 66%, and intracranial hemorrhage occurred in 43%. The rates of deep vein thrombosis and pulmonary thromboembolism in vaccinated patients were 13% and 23%, respectively, with a pooled case fatality rate of 30%.
    UNASSIGNED: The results of this overview indicate the majority of adverse reactions are self-limiting and require minimal intervention, while rare occurrences such as myocarditis and thrombosis pose a potentially fatal threat.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    关于三联疗法(包括长效β2激动剂,长效毒蕈碱拮抗剂,吸入皮质类固醇,LABA/LAMA/ICS)治疗慢性阻塞性肺疾病(COPD)的结果相互矛盾。随着合成数量的增加,识别和解释证据的任务变得越来越复杂和苛刻。
    对COPD三联疗法的疗效和安全性进行全面概述。
    SRs概述。
    两位独立的审阅者在PubMed中进行了全面的搜索,Embase,WebofScience,和Cochrane图书馆,以确定将三联疗法与任何非三联疗法进行比较的相关SR,从这些数据库开始到2023年6月1日。使用AMSTAR2和GRADE工具评估纳入研究的质量和每个结果的证据。
    分析了18项SR,包括30项原始研究,涉及47,340名参与者。总体AMSTAR2评级显示3个SR质量低,13个SR的质量极低,2个SR是高质量的。没有高确定性证据显示三联疗法在改善肺功能或减少急性加重方面具有显著优势。然而,所有的证据,包括一个高度的确定性,支持提高生活质量的好处。关于全因死亡率,与LAMA或ICS/LABA相比,没有发现显着差异;然而,与LABA/LAMA相比,高确定性证据证实了其有效性。值得注意的是,高确定性证据表明,与LABA/LAMA相比,三联疗法与肺炎风险显著增加相关.
    三联疗法在改善肺功能方面显示出显着益处,减少恶化,提高生活质量,降低全因死亡率。然而,值得注意的是,它也可能显著增加肺炎的风险。
    该概述协议在PROSPERO(编号:CRD42023431548)。
    UNASSIGNED: Some systematic reviews (SRs) on triple therapy (consisting of long-acting β2-agonist, long-acting muscarinic antagonist, and inhaled corticosteroid, LABA/LAMA/ICS) for chronic obstructive pulmonary disease (COPD) have reported conflicting results. As the number of syntheses increases, the task of identifying and interpreting evidence becomes increasingly complex and demanding.
    UNASSIGNED: To provide a comprehensive overview of the efficacy and safety of triple therapy for COPD.
    UNASSIGNED: Overview of SRs.
    UNASSIGNED: Two independent reviewers conducted comprehensive searches in PubMed, Embase, Web of Science, and the Cochrane Library to identify relevant SRs that compared triple therapy with any non-triple therapy for COPD, from the inception of these databases until 1 June 2023. The AMSTAR 2 and GRADE tools were utilized to assess the quality of the included studies and the evidence for each outcome.
    UNASSIGNED: Eighteen SRs encompassing 30 original studies and involving 47,340 participants were analyzed. The overall AMSTAR 2 rating revealed that 3 SRs were of low quality, 13 SRs were of critically low quality, and 2 SRs were of high quality. No high-certainty evidence revealed a significant advantage of triple therapy in improving lung function or reducing acute exacerbations. However, all evidence, including one high certainty, supported the benefits of improving quality of life. Regarding all-cause mortality, no significant difference was found when compared to LAMA or ICS/LABA; however, high-certainty evidence confirmed its effectiveness when compared with LABA/LAMA. Notably, high-certainty evidence indicated that triple therapy was associated with a significant increase in the risk of pneumonia compared to LABA/LAMA.
    UNASSIGNED: Triple therapy demonstrated notable benefits in improving lung function, reducing exacerbations, improving quality of life, and reducing all-cause mortality. However, it is important to note that it may also significantly increase the risk of pneumonia.
    UNASSIGNED: This overview protocol was prospectively registered with PROSPERO (No. CRD42023431548).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Endoscopic skull base surgery presents significant technical challenges and high surgical risks, requiring collaboration among multiple disciplines such as otolaryngology, neurosurgery, ophthalmology, and oral maxillofacial surgery. In recent years, there has been rapid development in endoscopic skull base surgery, characterized by flourishing anatomical research and an expanding range of surgical indications. The future brings both opportunities and challenges, and endoscopic skull base surgery must grasp new directions in medical development, actively providing patients with safer and more effective treatment options.
    摘要: 内镜颅底外科技术难度大,手术风险高,需要耳鼻喉科、神经外科、眼科、口腔颌面外科等多学科协作。近年来内镜颅底外科发展迅速,表现为解剖研究蓬勃发展,手术适应证日益扩大。未来机遇与挑战并存,内镜颅底外科需要把握未来医学发展新方向,积极为患者提供更安全、更有效的治疗方案。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)是常见的泌尿系疾病,病因复杂。西医治疗效果不理想,疾病的进程是漫长的,这给患者带来了很大的麻烦。中医有多种辨证论治的治疗方法,包括中医内部治疗,针灸和按摩,和其他综合治疗的外部治疗方法,具有显著的效果。本研究总结了CP/CPPS的病因病机,发现西医不能完全解释CP/CPPS的病因病机。认为CP/CPPS主要与特殊病原体感染等多种因素有关,排尿功能障碍,精神和心理异常,神经内分泌异常,免疫异常,过度的氧化应激,盆腔疾病,和遗传。中医认为CP/CPPS是由湿热引起的,血瘀,气滞,和中毒,与肝脏器官密切相关,脾,脾肾,肺,胃,膀胱,经脉的冲和仁道和三个阴道的脚。在中医治疗中,目前采用多种综合治疗方案,包括中医内服治疗(汤剂,中成药,和著名医生的独特疗法),针灸和按摩治疗,和其他外部治疗方法(直肠给药,中药的局部应用,和耳穴压力)。综合调理具有显著的临床疗效和突出的中医特色,值得临床推广。本研究旨在为临床预防和治疗CP/CPPS提供参考,并为该领域未来的研究指明可能的方向。
    Chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS) is a common urological disease with complex etiology. The treatment effect of western medicine is not satisfactory, and the course of the disease is protracted, which brings great trouble to patients. Traditional Chinese medicine(TCM) has a variety of treatment methods based on syndrome differentiation and treatment, including internal treatment with TCM, acupuncture and massage, and other external treatment methods for comprehensive treatment, with significant effect. This study summarized the etiology and pathogenesis of CP/CPPS and found that western medicine cannot fully explain the etiology and pathogenesis of CP/CPPS. It was believed that CP/CPPS was mainly related to many factors such as special pathogen infection, voiding dysfunction, mental and psychological abnormalities, neuroendocrine abnormalities, immune abnormalities, excessive oxidative stress, pelvic diseases, and heredity. TCM believed that CP/CPPS was caused by damp heat, blood stasis, Qi stagnation, and poisoning and was closely related to the organs of the liver, spleen, kidney, lung, stomach, bladder, and meridians of Chong and Ren channels and three yin channels of the foot. In the treatment of TCM, multiple comprehensive treatment plans are currently used, including internal treatment with TCM(decoction, proprietary Chinese medicine, and unique therapies of famous doctors), acupuncture and massage treatment, and other external treatment methods(rectal administration, topical application of TCM, and ear acupoint pressure). Comprehensive regulation has significant clinical efficacy and prominent characteristics of TCM, and it is worth clinical promotion. This study aims to provide a reference for clinical prevention and treatment of CP/CPPS and points out potential directions for future research in this field.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本研究旨在对针对残疾成年人的暴力行为领域的系统评价进行概述。搜索了8个电子数据库以及2022年1月至2023年4月的灰色文献,以确定针对残疾成年人的暴力行为的系统评价。该综述共纳入了13份高质量的系统综述。研究结果表明,残疾成年人的情感和身体暴力发生率高于普通人群。社会人口统计学,金融,和文化风险因素,预防,并对治疗方法进行了讨论。尽管关于残疾和暴力的大量研究探讨了这一问题的不同方面,文献中存在一些局限性和空白,需要进一步关注。文献中最重要的差距是缺乏对多样性的关注。因此,对不同地理位置的残疾和暴力知之甚少。此外,基于种族/种族的暴力研究,年龄,性别认同,某些类型的残疾,如听力障碍或严重残疾很少。有必要接触不同的残疾成年人群体,通过采用各种数据收集方法和定性研究方法。制定预防和治疗方案应注意残疾的类型,他们应该对文化和语言敏感。
    This study aimed to conduct an overview of systematic reviews in the field of violence against adults with disability. Eight electronic databases as well as gray literature from January 2022 to April 2023 were searched to identify systematic reviews that focused on violence against adults with disabilities. A total of 13 high-quality systematic reviews were included in the overview. Findings show that adults with disabilities experience a higher rate of emotional and physical violence than the general population. Sociodemographic, financial, and cultural risk factors, prevention, and treatment approaches were discussed. Although the large body of studies on disability and violence have explored different aspects of the issue, there are some limitations and gaps in the literature that need further attention. The most important gap in the literature is the lack of attention to diversity. Accordingly, there is little knowledge about disability and violence in a variety of geographical locations. In addition, studies on violence based on ethnicity/race, age, gender identifications, and some types of disabilities such as hearing impairments or severe disabilities were scarce. There is a need to reach diverse populations of adults with disabilities, through employing a variety of data collection methods and qualitative research methodology. Prevention and treatment programs should be developed with attention to types of disability, and they should be culturally and linguistically sensitive.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    总结针刺治疗中风偏瘫临床疗效的系统评价/荟萃分析结论,并评价其方法学质量和证据质量。
    两名研究人员搜索并提取了8个数据库进行系统评价(SRs)/荟萃分析(MA),并独立评估方法学质量,偏见的风险,报告质量,以及纳入随机对照试验(RCTs)的SRs/MA的证据质量。使用的工具包括评估多个系统评论2(AMSTAR-2),系统(ROBIS)量表中的偏差风险,系统评价和荟萃分析(PRISMA)的首选报告项目列表,和建议评估的分级,发展,和评估(等级)系统。搜索时间是从数据库建设到2023年7月。
    总共包括11个SR/MA,包括2篇英国文学和9篇中国文学,所有研究地点都在中国。AMSTAR-2评价结果表明,11篇文献的方法学质量被评为质量很低;根据ROBIS评价结果,SRs/MA被评估为偏差的高风险;根据PRISMA检查表评估的结果,大多数SR/MA报告相对完整;根据等级制度,从纳入的SR/MA中提取42项结果进行评估,其中1项被评为高质量证据,14作为中等质量的证据,14作为低质量的证据,和13个非常低质量的证据。
    现有证据表明针刺治疗中风偏瘫具有一定的临床疗效。然而,这项研究仍然存在一些局限性,如SRs/MAs方法和证据的质量较低,需要更多高质量的研究来验证它们。
    UNASSIGNED: Summarize the conclusions of the systematic review/meta-analysis of the clinical efficacy of acupuncture for stroke hemiplegia, and evaluate its methodological quality and the quality of evidence.
    UNASSIGNED: Two researchers searched and extracted 8 databases for systematic reviews (SRs)/meta-analyses (MAs), and independently assessed the methodological quality, risk of bias, reporting quality, and quality of evidence of SRs/MAs included in randomized controlled trials (RCTs). Tools used included the Assessment of Multiple Systematic Reviews 2 (AMSTAR-2), the Risk of Bias in Systematic (ROBIS) scale, the list of Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The search time is from database building to July 2023.
    UNASSIGNED: A total of 11 SRs/MAs were included, including 2 English literature and 9 Chinese literature, with all study sites in China. AMSTAR-2 evaluation results showed that the methodological quality of 11 articles was rated as very low quality; Based on the ROBIS evaluation results, the SRs/MAs was assessed as a high risk of bias; According to the results of the PRISMA checklist evaluation, most of the SRs/MAs reports are relatively complete; according to GRADE system, 42 outcomes were extracted from the included SRs/MAs for evaluation, of which 1 was rated as high-quality evidence, 14 as moderate-quality evidence, 14 as low-quality evidence, and 13 as very low-quality evidence.
    UNASSIGNED: The available evidence indicates that acupuncture has certain clinical efficacy in the treatment of stroke hemiplegia. However, there are still some limitations to this study, such as the lower quality of SRs/MAs methodologies and evidence included, and more high-quality studies are needed to verify them.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:维生素D(VitD)特性可以影响癌细胞。尽管有文献记载VitD水平与几种癌症类型的患病率之间存在联系,据报道,皮肤黑色素瘤(CM)的发现相互矛盾。目标:本概述旨在从现有的系统评价和荟萃分析中收集证据,强调VitD血清水平之间的关系,摄入量,受体(VDR)基因多态性,和CM风险。方法:在电子数据库中进行文献检索,基于某些纳入标准。结果:纳入21项研究。高VitD血清水平之间相互矛盾的证据,饮食/补充摄入量,CM风险被强调。VDR多态性可能在复杂的CM发病机制中起作用。此外,高血清VitD水平与改善CM预后相关。结论:本综述表明VitD对CM的影响尚不清楚,因此,建议进一步研究探索其对CM风险的真实影响大小。
    Background: Vitamin D (VitD) properties can impact cancer cells. Despite the documented link between VitD levels and prevalence of several cancer types, conflicting findings have been reported for cutaneous melanoma (CM). Objective: This overview aims to compile the evidence from existing systematic reviews and meta-analyses, emphasizing the relationships between VitD serum levels, intake, receptor (VDR) gene polymorphisms, and CM risk. Methods: A literature search in electronic databases was conducted, based on certain inclusion criteria. Results: Twenty-one studies were included. Conflicting evidence between high VitD serum levels, dietary/supplementary intake, and CM risk is highlighted. VDR polymorphisms may play a role in the intricate CM pathogenesis. Also, high serum levels of VitD are associated with improved CM prognosis. Conclusions: This overview showed that the impact of VitD on CM is not clear, and thus further research is suggested to explore its true effect size on CM risk.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本文分析了在“国际观点与倡议”定期专题系列中发表的关于技术对提供健康信息的影响的七篇文章。这些文章提供了技术如何为七个国家的图书馆用户提供新的和增强的服务的路线图:澳大利亚,孟加拉国,中国,英格兰,德国,瑞典和美国。尽管各国在实施技术解决方案方面存在差异,只有一个人描述了利用技术改善图书馆服务的问题。来自其余六个国家的作者描述了他们如何确保21世纪图书馆与其用户群体进行协商,并找到使用最新应用程序的方法。
    This article presents an analysis of seven articles published within the International Perspectives and Initiatives regular feature series on the impact of technology on the provision of health information. The articles provide a road map of how technology is facilitating new and enhanced services for library users in seven countries: Australia, Bangladesh, China, England, Germany, Sweden and the United States. Although there are differences in how countries are implementing technological solutions, only one describes problems in leveraging technology to improve library services. Authors from the remaining six countries describe how they ensure that the 21st century library consults with its user groups and find way of using the latest applications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    近年来,许多研究和许多数据源已经成为数字化。数字或基于互联网的研究的一些优势,与传统的实验室研究相比(例如,全面的数据收集和存储,数据的可用性)是改进荟萃分析方法的理想选择。同时,在荟萃分析研究中,已经开发了不同类型的荟萃分析,以提供具有准确定量估计的研究综合。由于其丰富而独特的修正调色板,我们建议在数字化世界中使用Schmidt和Hunter方法进行荟萃分析.我们的入门课程以逐步的方式展示了如何考虑数字数据进行高质量的荟萃分析,并突出了最明显的陷阱(例如,仅使用裸露的荟萃分析,没有数据比较)不仅在数据聚合中,而且在文献检索和编码过程中,这是任何荟萃分析中必不可少的步骤。因此,这种荟萃分析的入门特别适合于未来大部分研究将转向数字研究的情况。绘制基于互联网的研究地图并揭示任何研究差距,我们进一步综合了基于互联网的研究的荟萃分析(15篇文章包含24种不同的荟萃分析,在745项研究中,具有1,601个效果大小),导致了该领域的第一个大型荟萃分析。我们发现缺乏个体参与者数据(例如,年龄和国籍)。因此,我们为高质量的荟萃分析和大型荟萃分析提供了入门,适用于许多即将进行的研究,以及基本的动手知识,以在数字化世界中进行或判断荟萃分析的质量。
    In recent years, much research and many data sources have become digital. Some advantages of digital or Internet-based research, compared to traditional lab research (e.g., comprehensive data collection and storage, availability of data) are ideal for an improved meta-analyses approach.In the meantime, in meta-analyses research, different types of meta-analyses have been developed to provide research syntheses with accurate quantitative estimations. Due to its rich and unique palette of corrections, we recommend to using the Schmidt and Hunter approach for meta-analyses in a digitalized world. Our primer shows in a step-by-step fashion how to conduct a high quality meta-analysis considering digital data and highlights the most obvious pitfalls (e.g., using only a bare-bones meta-analysis, no data comparison) not only in aggregation of the data, but also in the literature search and coding procedure which are essential steps in any meta-analysis. Thus, this primer of meta-analyses is especially suited for a situation where much of future research is headed to: digital research. To map Internet-based research and to reveal any research gap, we further synthesize meta-analyses on Internet-based research (15 articles containing 24 different meta-analyses, on 745 studies, with 1,601 effect sizes), resulting in the first mega meta-analysis of the field. We found a lack of individual participant data (e.g., age and nationality). Hence, we provide a primer for high-quality meta-analyses and mega meta-analyses that applies to much of coming research and also basic hands-on knowledge to conduct or judge the quality of a meta-analyses in a digitalized world.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    阿尔茨海默病(AD)是一种普遍的神经退行性疾病,对个人和社会都产生重大影响。本研究旨在通过总结系统评价(SRs)和荟萃分析(MAs)的证据来评估重复经颅磁刺激(rTMS)作为AD治疗的有效性。
    通过搜索Embase收集AD的rTMS的SRs/MA,WebofScience,科克伦图书馆,PubMed,CNKI,VIP,中医学,和万方数据库。搜索从数据库创建到2024年1月23日进行。方法学质量,报告质量和偏倚风险使用评估方法质量系统评价2(AMSTAR-2),系统评价中的偏差风险(ROBIS)工具和系统评价和荟萃分析的首选报告项目(PRISMA)。此外,结果测量的证据质量使用建议分级进行评估,评估,开发和评估(等级)。
    本研究中包含的8个SR/MA符合纳入标准。根据AMSTAR-2,4个SR/MA被归类为低质量,而其余4则被认为质量很低。PRISMA分析显示,在报告的27个项目中,16个实现了完整报告(100%)。然而,报告仍然存在一些缺陷,特别是与协议和注册有关,搜索策略,偏见的风险,和额外的分析。ROBIS工具表明,只有3个SRs/MA具有低偏倚风险。等级评估显示,6项结果质量中等(18.75%),16个质量低(50%),10人被列为极低质量(31.25%)。
    根据收集的证据,rTMS似乎能有效改善AD患者的认知功能,尽管SRs/MA的方法学质量降低了结论的可靠性,总体质量较低。然而,根据现有的结果,我们仍然支持rTMS作为改善AD认知功能的干预措施的价值。在未来的研究中,有必要确认rTMS在AD患者中的疗效,并提供更可靠和科学的数据,为循证医学做出贡献。
    UNASSIGNED: Alzheimer\'s disease (AD) is a prevalent neurodegenerative condition that significantly impacts both individuals and society. This study aims to evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a treatment for AD by summarizing the evidence from systematic reviews (SRs) and meta-analyses (MAs).
    UNASSIGNED: SRs/MAs of rTMS for AD were collected by searching Embase, Web of Science, Cochrane Library, PubMed, CNKI, VIP, Sino-Med, and Wanfang databases. The search was conducted from database creation to January 23, 2024. Methodological quality, reporting quality and risk of bias were assessed using the Assessing Methodological Quality of Systematic Reviews 2 (AMSTAR-2), Risk of Bias in Systematic Reviews (ROBIS) tool and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). In addition, the quality of evidence for outcome measures was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE).
    UNASSIGNED: Eight SRs/MAs included in this study met the inclusion criteria. Based on the AMSTAR-2, 4 of the SRs/MA were classified as low quality, while the remaining 4 were deemed to be of very low quality. The PRISMA analysis revealed that out of the 27 items reporting, 16 achieved full reporting (100%). However, there were still some deficiencies in reporting, particularly related to protocol and registration, search strategy, risk of bias, and additional analysis. The ROBIS tool indicated that only 3 SRs/MAs had a low risk of bias. The GRADE assessment indicated that 6 outcomes were of moderate quality (18.75%), 16 were of low quality (50%), and 10 were classified as very low quality (31.25%).
    UNASSIGNED: Based on the evidence collected, rTMS appears to be effective in improving cognitive function in AD patients, although the methodological quality of the SRs/MAs reduces the reliability of the conclusions and the overall quality is low. However, based on the available results, we still support the value of rTMS as an intervention to improve cognitive function in AD. In future studies, it is necessary to confirm the efficacy of rTMS in AD patients and provide more reliable and scientific data to contribute to evidence-based medicine.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号